¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Natriuretic Peptide, Brain"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hypoxic brain injury
    Àú»ê¼Ò³ú¼Õ»ó
  • minimal brain dysfunction
    °æ¹Ì³ú±â´ÉÀå¾Ö
  • olfactory brain
    Èİ¢³ú
  • organic brain syndrome
    ±âÁú¼º³úÁõÈıº
  • primary brain vesicles
    ÀÏÂ÷³úÆ÷
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • signal peptide
    ½ÅÈ£ÆéƼµå
  • trypsinogen activation peptide(TAP)
  • urinary gonadotropin fragment/peptide
    ¿äÁß¼º¼±ÀÚ±ØÈ£¸£¸óºÐÀý/ÆéƼµå
  • vasoactive intestinal (poly)peptide
    Ç÷°üÀۿ뼺 ÀåÆéƼµå
  • acervulus cerebri =brain sand
    ³ú»ç(ÒàÞã).
  • acute brain disorder
    ±Þ¼º ³úÀå¾Ö (¡­Òàî¡äô).
  • acute brain syndrome
    ±Þ¼º ³úÁõÈıº(¡­Òàñøý¦ÏØ).
  • arachnoid of brain
    ³ú°Å¹Ì¸·
  • atypical or mixed organic brain syndrome
    ºñÁ¤Çü ³»Áö È¥ÇÕÇü ±âÁú¼º ³úÁõÈıº
  • blood brain barrier =BBB
    Ç÷³úÀ庮(¡­Òàî¡Ûú).
  • blood brain barrier=BBB
    Ç÷³úÀ庮(¡­Òàî¡Ûú).
  • blood-brain barrier
    Ç÷¾×-³ú À庮
  • blood-brain barrier
    Ç÷³úÀ庮(úìÒàî¡Ûú)
  • blood-brain barrier = BBB
    Ç÷³úÀ庮(¡­Òàî¡Ûú)
  • blood-brain/cerebrospinal fluid barrier
    Ç÷-³ú/³úô¼ö¾× À庮.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MBD Marchiafava-Bignami disease; Mental Deterioration Battery; methylene blue dye; minimal brain damage;...
ANF Atrial Natriuretic Factors
ANF alpha-naphthoflavone; American Nurses' Foundation; antineuritic factor; antinuclear factor; atrial n...
EDNF endogenous digitalis-like natriuretic factor
hANF human atrial natriuretic factor
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
HANP Human atrial natriuretic peptide
IR-ANP Immunoreactive atrial natriuretic peptide
NP Natriuretic peptide
NPR Natriuretic peptide receptor
NPR-C Natriuretic peptide receptor C
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • brain function mapping
    ³ú ±â´É ÁöµµÈ­
  • brain injury
    ³ú ¼Õ»ó
  • brain sand
    ³ú»ç
    ³úÀÇ ÀÏÁ¤ ºÎºÐ¿¡¼­ º¼ ¼ö ÀÖ´Â ÀÛÀº ¸ð·¡ ¸ð¾çÀÇ ´Ü´ÜÇÑ ÀÔÀÚ. ¼®È¸°¡ Ä§ÂøµÇ¾î »ý±ä °ÍÀÌ´Ù. ³ú»ç°¡ ¸ð¿© ÀÖ´Â ºÎÀ§´Â º¸Åë ¼Û°ú¼±°ú ±× ºÎ±ÙÀε¥ ÀþÀº »ç¶÷¿¡°Ô´Â ¾ø°í ³ëÀο¡°Ô ¸¹´Ù. ±×·¯¹Ç·Î À̰ÍÀº ÅðÈ­ Çö»óÀ¸·Î »ý°¢µÇ¸ç, ¶Ç ³ú»çÀÇ ³»ºÎ¿¡´Â ÁÙ¹«´Ì°¡ ÀÖ´Â °ÍÀ¸·Î º¸¾Æ óÀ½¿¡´Â ÀÛÀº °ÍÀÌ Â÷Â÷ Ä¿Áø °ÍÀ̶ó »ý°¢µÈ´Ù. µ¿½É¼ºÀÇ Çϳª ÇϳªÀÇ ³ú»ç ÇüÅ´ ±¸»óÀÌ ¸¹°í, Ç¥¸éÀº »Í³ª¹« ¿­¸Å ¸ð¾çÀ¸·Î ¿ïÅüºÒÅüÇÏ´Ù. ³ú»ç°¡ ÁÖ¼ººÐÀ¸·Î µÇ¾î °áÇÕÁ¶Á÷À̳ª Ç÷°ü°ú ¹¶ÃÄÁø µ¢¾î¸®°¡ µå¹°°Ô ³úÀÇ ³»ºÎ ¶Ç´Â ±× °¡±îÀÌ¿¡ »ý±â´Â °æ¿ì°¡ ÀÖ´Ù. ±×°ÍÀ» ³ú»çÁ¾À̶ó Çϴµ¥, À̰Ϳ¡ ÀÇÇÏ¿© ³ú Á¶Á÷ÀÌ ¾Ð¹Ú ¶Ç´Â ÆÄ±«µÇ¸é ±×¿¡ µû¸£´Â Áõ¼¼°¡ ³ªÅ¸³­´Ù. ¸Å¿ì Å« ³ú»çÁ¾ÀÌ Á¦ 4³ú½Ç¿¡ »ý°Ü ¼ö¾×ÀÇ È帧À» ¹æÇØÇÏ´Â ¿¹µµ ÀÖ´Ù.
  • brain stem
    ³ú°£
    ´ë³ú ¹Ý±¸¸¦ ô¼ö¿Í ¿¬°áÇÏ´Â ½Å°æÁ¶Á÷À¸·Î¼­ ¿¬¼ö, ³ú±³ ¹× Áß³ú·Î ±¸¼ºµÇ¾î ÀÖ´Ù.
  • brain stem reflex
    ³ú°£ ¹Ý»ç
  • brain stem syndrome
    ³ú°£ ÁõÈıº
  • brain vesicle`s
    ³úÆ÷
    ¹èÅ ºÐÈ­ ½Ã¿¡ º¸ÀÌ´Â Æó¼â ½Å°æ°üÀÇ ´Ù¼¸ ºÎºÐ.
  • brain vesicle`s secondary
    ÀÌÂ÷ ³úÆ÷
    Èı⠹èÅ ºÐÈ­·Î Çü¼ºµÇ´Â ³× °³ÀÇ ³ú³¶À¸·Î¼­ Àü³ú·ÎºÎÅÍ ºÐÈ­µÇ´Â Á¾³ú¿Í °£³ú, ´É³ú·ÎºÎÅÍ ºÐÈ­µÇ´Â Èijú¿Í ¼ö³ú¸¦ Æ÷ÇÔÇÑ´Ù.
  • brain weight
    ³ú Áß·®
  • chronic organic brain syndrome
    ¸¸¼º ±âÁú¼º ³ú ÁõÈıº
  • concussion of the brain
    ³ú ÁøÅÁ
    ³úÁøÅÁÀ̶õ ¶óƾ¾îÀÇ Concutere Áï Èçµç´Ù¶ó´Â ¶æÀÌ¸ç µÎºÎ ¿Ü»óÀ» ¹Þ¾Æ ¹Ý°íüÀÎ ³ú°¡ ´Ü´ÜÇÑ µÎ °³ °­ ¾È¿¡¼­ Èçµé·Á ÀϽÃÀûÀ¸·Î ³úÀÇ ±â´ÉÀÌ ÁߴܵǾú´Ù°¡ ¿ÏÀüÈ÷ ȸº¹µÇ¸ç ³ú ½ÇÁú¿¡ ±âÁúÀû º¯È­¸¦ ÀÏÀ¸Å°Áö ¾Ê´Â °¡¿ªÀûÀÎ °æÇÑ ³ú ¼Õ»óÀ¸·Î ±ÔÁ¤µÇ¾î ¿Ô´Ù. ±ÙÀÚ¿¡´Â ³ú ÁøÅÁÀ» ±âÁúÀû ³ú ¼Õ»óÀÇ ¿¬¼Ó¼±»ó¿¡ ÀÖ´Â ÇÑ À¯ÇüÀ¸·Î º¸¸ç, °æ¹ÌÇÑ ÇüÅÂÀÇ ¹Ì¸¸¼º Ãà»è ¼Õ»óÀ¸·Î º¸´Â Ãß¼¼¿¡ ÀÖ´Ù. ³úÁøÅÁ¿¡ ÀÇÇÑ ÀÇ½Ä »ó½Ç°ú ´õºÒ¾î ¿Ü»ó¼º ±â¾ï »ó½ÇÁõÀÌ ¹ß»ýÇϴµ¥, ±ú¾î³­ ÈÄ¿¡ ¿Ü»ó Á÷Àü ¶Ç´Â ¿Ü»ó Á÷ÈÄÀÇ ±â¾ïÀÌ ¼Ò½ÇµÊÀ¸·Î ¿ªÇ༺ ±â¾ï »ó½ÇÁõÀ̶ó°í ºÒ¸®¿ì¸ç ÀÌ·¯ÇÑ Çö»óÀº ´ë°³ 1ÀÏ ÀÌ»ó °è¼ÓµÇÁö ¾ÊÁö¸¸ °æ¿ì¿¡ µû¶ó¼­´Â ¸çÄ¥ ¶Ç´Â ¸î °³¿ù°£ Áö¼ÓµÇ´Â ¼ö°¡ ÀÖ´Ù. ¼Õ»óÀÇ Á¤µµ¿¡ µû¶ó ÀÇ½Ä »ó½Ç°ú ´õºÒ¾î Ç÷¾Ð »ó½Â, ¸Æ¹ÚÀÇ º¯È­, È£Èí ¸¶ºñ, µ¿°ø »ê´ë, ¹ßÇÑ ¹× ¹Ý»çÀÇ ¼Ò½ÇÀÌ ¹ß»ýµÇ±âµµ ÇÏ¸ç ±â´É ¼Ò½ÇÀÇ Á¤µµ¿Í ±â°£Àº ±ÇÅõ¿Í °°Àº ¿îµ¿¿¡¼­ º¼ ¼ö ÀÖ´Â ¹Ýº¹µÈ Ãæ°Ý¿¡ ÀÇÇØ ´©ÀûµÇ°í Áõ´ëµÈ´Ù.
  • degenerative brain disease
    ÅðÇ༺ ³ú Áúȯ
  • fluid brain barrier
    ü¾× ³ú À庮
  • functional brain imaging
    ±â´ÉÀû ³ú ¿µ»ó
  • hind brain
    Èijú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
peptide library A collection of cloned free peptides, frequently consisting of all possible combinations of amino acids making up an n-amino acid peptide.
(12 Dec 1998)
peptide map Proteases will produce fragments of a characteristic size from a protein and this can be used as a test for the identity or otherwise of two similar sized proteins. It is possible to produce a peptide fragment map from a single gel band.
(18 Nov 1997)
peptide mapping Two-dimensional separation and analysis of peptides.
(12 Dec 1998)
peptide N-alpha acetyltransferase <enzyme> Pituitary enzyme; acetylates peptide hormones including acth; also found in saccharomyces cerevisiae
Registry number: EC 2.3.1.88
Synonym: peptide acetyltransferase, acth acetyltransferase, beta-endorphin acetyltransferase, alpha-msh acetyltransferase
(26 Jun 1999)
peptide neurotransmitter Small peptides used as primary or co transmitters in nerve cells for example FMRF amide, FLRFamide.
(18 Nov 1997)
peptide peptidohydrolases <enzyme> A subclass of enzymes of the hydrolase class that catalyses the hydrolysis of peptide bonds. These comprise the exopeptidases and endopeptidases, also called peptide hydrolase.
Registry number: EC 3.4.-
(12 Dec 1998)
peptide permease <chemical> In candida albicans
Chemical name: permease, peptide, (oc-6-63)-
Synonym: peptide transport system
(26 Jun 1999)
peptide phi A 27-amino acid peptide with histidine at the n-terminal and isoleucine amide at the c-terminal. The exact amino acid composition of the peptide is species dependent. The peptide is secreted in the intestine, but is found in the nervous system, many organs, and in the majority of peripheral tissues. It has a wide range of biological actions, affecting the cardiovascular, gastrointestinal, respiratory, and central nervous systems.
(12 Dec 1998)
peptide receptor Specific receptor for peptide neurotransmitters.
(18 Nov 1997)
peptide synthases <enzyme> Enzymes that catalyze the joining of an acid and an amino acid by the formation of a carbon-nitrogen bond.
Registry number: EC 6.3.2.
(12 Dec 1998)
peptide synthetase Any enzyme that catalyses the synthesis of peptide bonds, with the hydrolysis of a nucleoside triphosphate.
(05 Mar 2000)
peptide t <chemical> N-(n-(n(2)-(n-(n-(n-(n-d-alanyl l-seryl)-l-threonyl)-l-threonyl) l-threonyl)-l-asparaginyl)-l-tyrosyl) l-threonine. Octapeptide sharing sequence homology with HIV envelope protein gp120. It is potentially useful as antiviral agent in aids therapy. The core pentapeptide sequence, ttnyt, consisting of amino acids 4-8 in peptide t, is the HIV envelope sequence required for attachment to the CD4 receptor.
Chemical name: L-Threonine, N-(N-(N2-(N-(N-(N-(N-D-alanyl-L-seryl)-L-threonyl)-L-threonyl)-L-threonyl)-L-asparaginyl)-L-tyrosyl)-
(12 Dec 1998)
peptide termination factors Proteins that are exclusively involved in the termination reactions of protein synthesis on the ribosome.
(12 Dec 1998)
peptide-tryptophan 2,3-dioxygenase <enzyme> Catalyses the oxidation of peptide tryptophan to form peptide formylkynurenine
Registry number: EC 1.13.11.26
Synonym: tryptophan pyrrolooxygenase
(26 Jun 1999)
peptide yy A 36-amino acid peptide produced by the l cells of the distal small intestine and colon. Peptide yy inhibits gastric and pancreatic secretion.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á